Liberia vs Rwanda: Tuberculosis patients living with HIV receiving antiretroviral therapy
Liberia
705 patients
in 2021
Rwanda
697 patients
in 2021
Liberia rank
40th
Rwanda rank
41st
Tuberculosis patients living with HIV receiving antiretroviral therapy over time
- Liberia
- Rwanda
How they compare
Liberia currently reports 705 patients against 697 patients in Rwanda, a difference of 8 patients.
The two have swapped places 1 time across 14 shared years of data; in 2008 it was Rwanda ahead.
Liberia ranks 40th and Rwanda ranks 41st of 183 countries.
Rwanda has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Liberia | Rwanda | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 30 patients | 1,560 patients | 1,530 patients | Rwanda |
| 2010s | 283.7 patients | 1,240 patients | 956.1 patients | Rwanda |
| 2020s | 695 patients | 837 patients | 142 patients | Rwanda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis patients living with hiv receiving antiretroviral therapy, Liberia or Rwanda?
- Liberia, at 705 patients against 697 patients in Rwanda as of 2021.
- What is the difference in tuberculosis patients living with hiv receiving antiretroviral therapy between Liberia and Rwanda?
- 8 patients, with Liberia ahead.
- How many years of comparable data are there for Liberia and Rwanda?
- 14 years are reported by both, from 2008 to 2021.
- How do Liberia and Rwanda rank globally for tuberculosis patients living with hiv receiving antiretroviral therapy?
- Liberia ranks 40th and Rwanda ranks 41st of 183 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.